Integrated Genetic and Proteomic Analysis Identifies PLK1 as a Candidate Therapeutic Target for SETD2-Deficient Clear Cell Renal Cell Carcinoma
Ontology highlight
ABSTRACT: We systematically analyzed the alterations in histone epigenetic marks (H3K36me3 and H4K16ac), mRNA transcriptome evoked by SETD2 depletion.
ORGANISM(S): Homo sapiens
PROVIDER: GSE107391 | GEO | 2018/11/22
REPOSITORIES: GEO
ACCESS DATA